A higher proportion of subjects with dysglycemic states (specially IFG), metabolic syndrome, and FINDRISC scores related to moderate and high risk of developing diabetes were observed in CCD group, especially in those with reactivity to anti-β2AR Abs. Here, ADRB2 is linked to metabolic syndrome.